Asia · General news · The Korea Herald

GC Biopharma, Hanmi Pharm strike $475m Fabry disease drug deal with BioMarin

Published by The Korea Herald · South Korea 9 h ago

GC Biopharma and Hanmi Pharmaceutical announced on Friday that they have signed an exclusive licensing-out agreement with US biotech company BioMarin Pharmaceut ...

Read the full article on The Korea Herald Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.koreaherald.com)

Also worth reading

CNA

Big Tech returns smallest share of cash to shareholders in 15 years, given AI spending

The Straits Times

Israel demolishes gunmen's homes in West Bank operation that has displaced thousands

Times of India

Penn's Cave, family-owned since 1908, goes up for sale for $34 million after 118 years

Philippine Daily Inquirer

PBA: Gomez de Liaño, Converge turn Game 1 loss into wake-up call

Hindustan Times

US drops G20 group photo plans amid European diplomats' opposition to Russia's Sergey Lavrov

The Mainichi